Recap: Pieris Pharmaceuticals Q1 Earnings

Pieris Pharmaceuticals PIRS reported its Q1 earnings results on Wednesday, May 10, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Pieris Pharmaceuticals missed estimated earnings by 28.57%, reporting an EPS of $-0.18 versus an estimate of $-0.14.

Revenue was down $9.05 million from the same period last year.

Last quarter the company beat on EPS by $0.12 which was followed by a 2.83% drop in the share price the next day.

Here's a look at Pieris Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.23	-0.16	-0.11	-0.11
EPS Actual	-0.11	-0.13	-0.14	-0.07
Revenue Estimate	6.51M	2.26M	10.47M	11.30M
Revenue Actual	5.85M	5.37M	3.70M	10.99M

To track all earnings releases for Pieris Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar